Form 8-K - Current report:
SEC Accession No. 0001558370-22-015128
Filing Date
2022-10-20
Accepted
2022-10-20 16:01:53
Documents
15
Period of Report
2022-10-19
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K kala-20221019x8k.htm   iXBRL 8-K 50252
2 EX-3.1 kala-20221019xex3d1.htm EX-3.1 17415
3 EX-99.1 kala-20221019xex99d1.htm EX-99.1 20999
4 GRAPHIC kala-20221019xex99d1001.jpg GRAPHIC 8886
  Complete submission text file 0001558370-22-015128.txt   236661

Data Files

Seq Description Document Type Size
5 EX-101.SCH kala-20221019.xsd EX-101.SCH 3128
6 EX-101.LAB kala-20221019_lab.xml EX-101.LAB 16573
7 EX-101.PRE kala-20221019_pre.xml EX-101.PRE 10516
9 EXTRACTED XBRL INSTANCE DOCUMENT kala-20221019x8k_htm.xml XML 5108
Mailing Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476
Business Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476 781-996-5252
Kala Pharmaceuticals, Inc. (Filer) CIK: 0001479419 (see all company filings)

EIN.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38150 | Film No.: 221321266
SIC: 2834 Pharmaceutical Preparations